Results 91 to 100 of about 1,858 (192)
Background: Cerebral cavernous malformations (CCMs) are vascular lesions linked to mutations in the CCM1, CCM2, and CCM3 genes, resulting in angiogenesis dysregulation.
Olga Belousova +4 more
doaj +1 more source
The intracellular scaffold KRIT1/CCM1 is an established regulator of vascular barrier function. Loss of KRIT1 leads to decreased microvessel barrier function and to the development of the vascular disorder Cerebral Cavernous Malformation (CCM).
Luca Goitre +12 more
doaj +1 more source
Background Familial cerebral cavernous malformations (CCMs), characterized by hemorrhagic stroke, recurrent headache and epilepsy, are congenital vascular anomalies of the central nervous system. Familial CCMs is an autosomal dominant inherited disorder and three CCM genes have been identified.
Xue, Wang +8 more
openaire +2 more sources
Monogenic signs of susceptibility to ischemic stroke: literature review
Genetic factors are the important chain in the complex conditions determining the development of ischemic stroke. Mutations have different significance for the risk of its development.
Vitaliy Tsymbaliuk, Iryna Vasileva
doaj +1 more source
Rho kinase inhibition rescues the endothelial cell cerebral cavernous malformation phenotype
Cerebral cavernous malformations (CCM) are vascular lesions causing seizures and stroke. Mutations causing inactivation of one of three genes, ccm1, -2, or -3, are sufficient to induce vascular endothelial cell defects resulting in CCM.
Borikova, Asya L. +3 more
core +3 more sources
Association of cardiovascular risk factors with disease severity in cerebral cavernous malformation type 1 subjects with the common Hispanic mutation. [PDF]
BackgroundCerebral cavernous malformations (CCM) are enlarged vascular lesions affecting 0.1-0.5% of the population worldwide and causing hemorrhagic strokes, seizures, and neurological deficits.
Khan, Yasir +9 more
core +1 more source
Abstract 1645: CEACAM1-blockade for T-cell activation and antitumor T-cell response
Immune checkpoint blockade became the most powerful way to control cancer without causing tremendous side effects, since anti-PD-1 blocking antibodies proved their superiority in clinical outcomes to those of traditional chemo- or targeted therapeutics ...
So-Young Eun
core +1 more source
Role of CCM1 loss-of-function-induced endothelial-to-mesenchymal transition in the development of cavernous malformations [PDF]
pre-printCerebral cavernous malformations (CCM) occur in two variants: sporadic and familial. Mutations in three genes-CCM1, CCM2, and CCM3-play a role in both subtypes, with mouse models showing the development of multiple cavernous malformations in ...
Couldwell, William T., Guan, Jian
core
Cerebral cavernous malformations are focal vascular abnormalities that show recurrent intralesional microhemorrhage and may cause focal deficits or seizures in affected patients. These lesions occur in both sporadic and inherited autosomal dominant form.
Zhu, Yuan +5 more
core +1 more source
Zerebrale Kavernomatose - Identifizierung tief-intronischer Varianten in den genomischen Regionen von CCM1, CCM2 und CCM3 mittels Hochdurchsatzsequenzierung [PDF]
Zerebrale kavernöse Malformationen (CCM) sind autosomal-dominant vererbbare zerebrovaskuläre Fehlbildungen, die mit unvollständiger Penetranz zu Kopfschmerzen, Krampfanfällen und hämorrhagischen Schlaganfällen führen können.
Jenssen, Sönke Elisabeth
core

